BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer. - Rouanne, Mathieu; Adam, Julien; Radulescu, Camélia; Letourneur, Diane; Bredel, Delphine; Mouraud, Séverine; Goubet, Anne-Gaëlle; Leduc, Marion; Chen, Noah; Tuan Zea Tan; Signolle, Nicolas; Bigorgne, Amélie; et al. (Journal of Clinical Investigation, 2022)